相关实验视频

Updated: Feb 28, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

在急性肺栓塞中,ABO血型和基于生物标志物的风险:回顾性队列研究

Abdulkader Jamal Eddin^1,2,3, Stefan Iulian Stanciugelu^4,5, Arnaldo Dario Damian⁶

¹Doctoral School, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timişoara, Romania.

Journal of clinical medicine

|February 27, 2026

概括

ABO血型不会影响生物标志物水平或预测急性肺栓塞 (PE) 结果的能力. 早期PE结果主要与右心室应变,炎症和功能有关.

科学领域:

心脏病学心脏病学
血液学血液学血液学
肺部医学肺部医学

背景情况:

非O ABO血型与增加静脉血栓栓塞的风险有关.
ABO类型对急性肺栓塞 (PE) 生物标志物和预后的影响尚不清楚.
这项研究研究了ABO血型对基线生物标志物的影响以及急性PE的短期结果.

研究的目的:

为了确定ABO血型是否影响急性PE患者呈现时的生物化学特征.
评估 ABO 类型是否会改变急性 PE 中常见生物标志物的预后值.
检查 ABO 血型,基线生物标志物和急性 PE 的短期临床结果之间的关系.

主要方法:

317名成年患者的回顾性队列研究,计算机断层扫描肺动脉扫描验证PE.
对共变量调整后的物流回归分析,以评估生物标志物-结果关联.
探索相互作用术语以评估ABO类型对生物标志物-结果关系的修改.

主要成果:

基线生物标志物水平在ABO血型中是相似的;没有发现与非O型的独立关联.
NT-proBNP,CRP和前素预测了住院死亡率;NT-proBNP,前素和CK-MB预测了严重的PE.
ABO类型没有显著改变生物标志物-结果关联,除了与感染的潜在相互作用.

结论:

在急性PE中,ABO血型不会影响基线生物标志物概况.
ABO类型不会影响急性PE预测结果的关键生物标志物的预后性能.
急性PE的短期结果是由右心室应变,炎症和功能障碍指标驱动的.

关键词:

有ABO血型的人有ABO血型.在 CK-MB 里.在CRP中使用CRP.D-二聚子 D-二聚子 NT-proBNP 的国家统计.生物标志物生物标志物这是什么意思? procalcitonin.肺栓塞肺栓塞是一种肺栓塞.这是一种血症.静脉血栓塞栓症是一种静脉血栓塞栓.

更多相关视频

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

相关概念视频

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

The ABO Blood Group

The ABO Blood Group

The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Pulmonary Embolism III: Nursing Management

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...